The essential oil from aerial parts of Conyza bonariensis (L) Cronquist collected in Mérida was obtained by hydrodistillation and analysed by GC/MS. The major components were trans-β-farnesene (37.8%), trans-ocimene (20.7%) and β-sesquiphellandrene (9.8%). Cytotoxicity assay was also performed with the essential oil against HeLa (cervix carcinoma), A-459 (lung carcinoma) and MCF-7 (breast adenocarcinoma) human cell lines and against normal Vero cells (African green monkey kidney) with IC 50 values ranging from 1.4 to 45.8 µg/mL. Additionally, the essential oil presented a significant bactericidal effect against Bacillus cereus, while a moderate activity was observed against Staphylococcus epidermidis and Candida albicans.
The genus Conyza belongs to the family Asteraceae and comprises about seventeen species of annual, biennial and perennial herbs, particularly inhabiting temperate and mountains regions [1] . In Venezuela, seven species have been reported: Conyza canadensis (L.) Cronquist, C. laevigata (Rick) Pruski, C. primulifolia (Lam.) Cuatrec. & Lourteig, C. sumatrensis (Retz.) E. Walker, C. uliginosa var. columbiana (Hieron.) Cuatrec., C. uliginosa var. uliginosa (Benth.) Cuatrec. and C. bonariensis (L) Cronquist [2] .
The medicinal uses attributed to Conyza species include the treatment of malaria [3] and wounds [4] , as well as antibacterial, antioxidant, cytotoxic [5] , antiinflammatory [6] , analgesic [7] , antiviral [8], antiproliferative [9] , antischistosomal [10] , antiprotozoal [11] and antidiarrheic activities [12] . Particularly, C. bonariensis has been used for the treatment of headache [13] , cutaneous leishmaniasis [14] and for its antibacterial activity [15] . Previous investigations of C. bonarienses have revealed glycosides, polyphenolic compounds, flavonoids and sesquiterpenic lactones [16] . The essential oil composition of this species has also been studied [17] .
For decades many researchers have carried out studies on the chemical composition and biological activities of essential oils obtained from different aromatic species, a review of which has been published recently [18] . These studies have revealed a variety of therapeutic and pharmacological effects [19] , including suppressive activity on human cancer cell lines including glioma, colon, gastric, human liver, pulmonary, breast and leukemia [20] . Additionally, antioxidant or free radical scavenger activity has been attributed to some essential oils [21] showing their potential as natural antioxidants to prevent oxidative stress and, therefore, many degenerative diseases.
In the present investigation, the chemical constituents, antibacterial and cytotoxic activities of the essential oil of C. bonariensis, collected in Mérida, Venezuela have been evaluated. To the best of our knowledge, this is the first report on the cytotoxic activity of this species. Gas chromatography (GC) and gas chromatography- mass spectrometric (GC-MS) analysis were conducted to establish the composition of C. bonariensis essential oil. A total of 13 compounds were identified (Table 1) , representing 92.8% of the total oil; sesquiterpene type components were predominant (59.5%).
Trans-β-farnesene (37.8%), trans-ocimene (20.7%) and β-sesquiphellandrene (9.8%) were present as major components. Arabia yielded δ-cadinene and ledol [23] , while from C. canadensis collected in China, limonene, α-bergamotene, and trans-β-farnesene were observed in major proportions [24] .
In the present investigation the essential oil of C. bonariensis, when subjected to antimicrobial activity testing, showed the highest activity against B. cereus (MIC 25-50 g/mL), while a moderate effect was observed against S. epidermidis and C. albicans (MIC 100-200 g/mL). In comparison, the standard antibiotic, cefotaxime had MIC values of 10 and 2.5 g/mL against B. cereus and S. epidermidis, respectively. No activity was detected against the other tested Gram-positive and Gram-negative bacterial strains.
Only few studies on the antimicrobial activity of the essential oil of C. bonariensis have been previously reported, which showed activity against yeasts (Candida parapsilosis and C. krusei) and fungi (Aspergillus flavus and A. fumigatus), with MIC values of ˃ 500 µg/mL [25] . However, antimicrobial activity has been reported for aqueous and ethanolic extracts of this species carried out by the agar-disk diffusion method [15] .
The cytotoxic activity of the essential oil of C. bonariensis was also assessed, in vitro, against a representative panel of cancer cell lines, HeLa (cervix carcinoma), A-549 (lung carcinoma), and MCF-7 (breast adenocarcinoma), along with normal cells {Vero (African green monkey kidney)} using 6-mercaptopurine as a positive control ( Table 2 ). a: Lag phase, b: Log phase, c 6-mercaptopurine (positive control). All assays were repeated at least three times. Table 2 , the essential oil proved to be active against the tested tumor cell lines, especially HeLa (IC 50 1.41 µg/mL) cells after 48 h of exposure. The cytotoxic activity always decreased when the oil was incorporated in the growth log phase, indicating that the mechanism of action must be by biosynthesis of Ecadherins. It is important to emphasize that C. bonariensis essential oil showed a rather selective cytotoxic activity against HeLa and MCF-7 cell lines, showing indexes of 20.6 and 1.4, respectively, as demonstrated by their higher IC 50 values against the non-tumor mammalian Vero cells. Essential oil isolation: Fresh leaves (1000 g) were subjected to hydrodistillation for 4 h using a Clevenger-type apparatus. The oil (0.4 mL) was dried over anhydrous sodium sulfate and stored in sealed vials at + 4°C in the dark until analyzed and tested. The yield (0.04%) was calculated based on the dry weight of the plant material.
As shown in
Gas chromatography: GC analyses were performed on a Perkin-Elmer Auto System gas chromatograph equipped with flame ionization detectors. A 5% phenylmethylpolysiloxane fused-silica capillary column (AT-5, Alltech Associates Inc., Deerfield, IL), 60 m x 0.25 mm, film thickness 0.25 µm, was used for the GC analysis. The initial oven temperature was 60°C; this was then raised to 260°C at 4°C/min, and the final temperature maintained for 20 min. The injector and detector temperatures were 200°C and 250°C, respectively. The carrier gas was helium at 1.0 mL/min. The sample was injected using a split ratio of 1:100. Retention indices were calculated relative to C 8 -C 24 n-alkanes, and compared with values reported in the literature [26a,b] .
Gas chromatography-mass spectrometry:
The GC-MS analyses were carried out on a Hewlett Packard GC-MS system, Model 5973, fitted with a 30 m long, cross-linked 5% phenylmethylsiloxane (HP-5MS, Hewlett Packard, USA) fusedsilica column (0.25 mm, film thickness 0.25 µm). The source temperature was 230°C, the quadrupole temperature 150°C, and the carrier gas helium, adjusted to a linear velocity of 34 m/s. The ionization energy was 70 eV, and the scan range 40-500 amu at 3.9 scans/s. The injected volume was 1.0 µL of a 2% dilution of oil in n-heptane. A Hewlett-Packard ALS injector was used with a split ratio of 1:100. The identification of the oil components was based on the Wiley MS Data Library (6th Ed), followed by comparisons of MS data with published literature [26a] .
Antimicrobial activity: Antimicrobial activity was determined against Gram-positive (Bacillus subtilis CECT39, B. cereus CECT496, Staphylococcus aureus ATCC 6538, S. epidermidis CECT232, S. saprophyticus CECT 235, Enterococcus faecalis CECT735), and Gram-negative (Escherichia coli CECT99, Proteus mirabilis CECT 170, Pseudomonas aeruginosa AK 958) bacteria, and Candida albicans CECT 1039 (yeast).The bacterial cultures were developed in either nutrient broth (NB) or brain heart infusion broth (for E. faecalis containing 0.06%Tween 80), and the yeast was cultured in Sabouraud liquid medium at 37°C. All media were purchased from Oxoid. The minimal inhibitory concentration (MIC) was determined for each sample in triplicate, using the broth microdilution method [27] . All samples were dissolved in DMSO; several wells were also filled with the same proportions of DMSO as the controls and never exceeded 1%, v/v. The starting microorganism concentration was approximately 1-5 × 10 5 CFU/mL; growth was monitored by measuring the optical density increase at 550 nm (OD 550 ) using a microplate reader (Multiskan Plus II). The MIC was defined as the lowest concentration of the essential oil where growth inhibition was observed after 24 h of incubation in a rotatory shaker at 37°C. All wells with no visible growth were sub-cultured by transferring 100 µL to either nutrient brain-heart infusion or Sabouraud agar plates. After overnight incubation, colony counts were performed and the MBC was defined as the lowest concentration of the essential oil that produced ≥ 99.9% killing of the initial inoculum.
Cytotoxic activity:
HeLa, A-549, MCF-7, and Vero cell lines were grown as a monolayer in Dulbecco's modified Eagle's medium, DMEM (Sigma), supplemented with 5% fetal calf serum (Gibco) and 1% of penicillin-streptomycin mixture (10,000 µL). Cells were maintained at 37°C in 5% CO 2 and 98% humidity. Cytotoxicity was assessed using the colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide] reduction assay [28] . Exponentially growing cell suspensions (0.1 mL of 2 x 104 cells/well) were incubated in a microtiter well plate (96-well Iwaki) along with the essential oil, pre-dissolved in DMSO, at different concentrations. After 48 h, the optical density was measured using a micro ELISA reader (Multiskan Plus II) at 550 nm after dissolving the MTT formazan in DMSO (150 µL). The viability percentage was plotted against the sample concentration, and the 50% cell 
